Investor Relations

Executive Management Team

Cheryl Blanchard
On April 26, 2020, Cheryl Blanchard, Ph.D. was appointed President and Chief Executive Officer, after serving as interim Chief Executive Officer since February 2020. Dr. Blanchard joined the Board of Directors of Anika Therapeutics, Inc. in August 2018. Prior to her work as an executive officer with Anika, she served as the President and Chief Executive Officer of Microchips Biotech, Inc., a venture-backed biotechnology company developing regenerative medicine and drug delivery products, from 2014 until its sale to Daré Bioscience, Inc. in November 2019. From 2012 to 2020, Dr. Blanchard has also been a Principal at Blanchard Consulting, LLC which provides scientific, regulatory, and business strategy consulting services to medical device companies and private equity clients. From 2000 to 2012, she served in various officer positions of Zimmer, Inc. (now Zimmer Biomet), a medical device company focused on musculoskeletal products, including as the Senior Vice President, Chief Scientific Officer, and general manager of Zimmer Biologics. She was also a member of Zimmer’s executive committee and founded, built and led Zimmer’s Joint Preservation/Regenerative Medicine business. Prior to joining Zimmer, Dr. Blanchard built and led the medical device practice at Southwest Research Institute. She has served as a director of Daré Bioscience, Inc. (NASDAQ: DARE), a publicly held leader in women’s health innovation, since November 2019. Dr. Blanchard received her M.S. and Ph.D. in Materials Science and Engineering from the University of Texas at Austin and received her B.S. in Ceramic Engineering from Alfred University. Until her appointment as interim Chief Executive Officer, Dr. Blanchard served as a member of Anika’s Compensation Committee and Governance and Nominating Committee.
Michael Levitz

On August 10, 2020, Michael Levitz was appointed Executive Vice President, Chief Financial Officer and Treasurer. Prior to joining Anika, Mr. Levitz served as Senior Vice President, Chief Financial Officer and Treasurer of Insulet Corporation, a global innovative medical device and drug delivery company. From 2009 to 2015, he was the Senior Vice President, Chief Financial Officer and Treasurer of Analogic Corporation, a global provider of medical guidance, diagnostic imaging and threat detection equipment. Previously, during his seven years with Hologic, Inc. and Cytyc Corporation (which merged with Hologic in October 2007), Mr. Levitz served in various capacities including Vice President and Corporate Controller. He began his career in the high technology audit practice at Arthur Andersen LLP. In 2011, he was a finalist for the Boston Business Journal's Chief Financial Officer of the Year award.

Mr. Levitz earned his Bachelor of Arts in Business Economics, with emphasis in Accounting, from the University of California Santa Barbara and is a certified public accountant. 

James Loerop Headshot

Jim Loerop joined Anika Therapeutics on July 8th, 2019 as the Company’s Executive Vice President of Business Development and Strategic Planning. Most recently, Mr. Loerop served as Chief Corporate Development Officer for Lupin Pharmaceuticals where he was a member of the company’s Executive Leadership Team and was responsible for global business development and corporate development activities. Prior to his work with Lupin, Jim held senior leadership roles at various companies in the pharmaceutical and life sciences industry, including at Alexion Pharmaceuticals as Senior Vice President of Global Business Development, GlaxoSmithKline as Vice President of North America Business Development, and Steifel Laboratories as Senior Vice President of Global Corporate Development prior to GSK’s acquisition of Stiefel. 

Mr. Loerop holds a B.S. in Marketing from Western Michigan University.

David Colleran placeholder image

David Colleran joined Anika Therapeutics, Inc. on March 4, 2020 as the Company’s Executive Vice President, General Counsel and Corporate Secretary. Mr. Colleran leads Anika’s global legal organization, including corporate governance and compliance. Most recently, David served as Senior Vice President, General Counsel, Corporate Secretary and Chief Compliance Officer at Insulet Corporation, a publicly traded, global medical device and drug delivery company. Prior to Insulet, he held the role of Vice President and General Counsel at Covidien, a global manufacturer of medical devices and supplies acquired by Medtronic, and Corporate Counsel at Ocean Spray Cranberries.  Mr. Colleran began his career as a corporate attorney at Choate, Hall & Stewart.

David holds a B.A. in Political Science from Boston College and a J.D. from Boston College Law School, and he is admitted to the Massachusetts Bar.

Photo Thomas Finnerty

Tom Finnerty joined Anika Therapeutics, Inc. as the Company’s Chief Human Resources Officer on October 30, 2017.  Most recently, Tom was a strategic human capital consultant with Anika Therapeutics. Prior to his work at Anika, Tom was the Senior Vice President of Human Resources at Smith & Nephew where he was responsible for delivering value added programs, processes, and leadership in all areas of global human capital management to over 10,000 employees. Prior to his time at Smith & Nephew, Mr. Finnerty served as Executive Director of Human Resources at Novartis/Chiron Diagnostics. Tom launched his career in human resources at The Foxboro Company, a global enterprise focused on designing and manufacturing innovative process control products and systems.

Tom holds a Masters in Business Administration from Babson College, and a Bachelor of Science in Business from the University of Massachusetts. 

James Chase photo

On May 29, 2020, James Chase was appointed as Senior Vice President of International Sales and Marketing. Mr. Chase first joined Anika Therapeutics, Inc. in August of 2018. Prior to Anika, James served as the Business Unit Director of the Sports Medicine Division of Smith & Nephew for the United Kingdom and Ireland. Prior to this role, Mr. Chase held several senior level leadership roles at Smith & Nephew, including General Manager UK/Ireland, Vice President Northern Europe, and Managing Director UK/Ireland. In these roles, he has successfully led large commercial teams generating revenue in excess of $300m.


James holds B.E. in Electrical Engineering from Plymouth University (Honors), and an M.B.A. from The Open University.

Steven Ek

On May 29, 2020, Steven Ek was appointed as Vice President of Research and Development. Steve joined Anika Therapeutics, Inc. in February of 2020 following the acquisition of Arthrosurface, Inc. Steve brings over 30 years of product development experience to Anika. Most recently, Mr. Ek had served as President and CEO of Arthrosurface, Inc., which he Co-Founded in 2002. Prior to this role, Steve held several senior level research and development and engineering roles at Smith & Nephew, CONMED Corp., and Primo Medical Group.

Steve holds a B.E. in Materials Science and Engineering from the University of Florida.

Ben Joseph

Ben Joseph joined Anika in August 2020 from Mend Medical, a healthcare portfolio company of Ambassador Enterprises where he was President and General Manager. Mr. Joseph spent over 10 years at Zimmer Biomet in key positions in the Sports Medicine and the Extremities business segments. He has held roles including Director of US Commercialization and Director of Marketing. In his last role at Zimmer Biomet, Mr. Joseph was the General Manager of the Global Foot and Ankle Business, and key initiatives included portfolio rationalization, product development focus, re-branding, and the build-out of a specialized sales channel. Throughout his tenure at Zimmer Biomet, he had a track record of building excellent teams and delivering consistent top and bottom line growth. Mr. Joseph holds a B.S. in Business Management and an M.B.A. from the Indiana University Kelley School of Business.


Mira Leiwant joined Anika Therapeutics, Inc. as the Company’s Vice President of Regulatory Affairs, Quality, and Clinical Affairs on October 1, 2019.  Most recently, Mira was Vice President of Regulatory Affairs at BTG International where she was responsible for the leadership of Interventional Oncology Regulatory functions and activities within the organization. Prior to her work at BTG International, Mira was the Senior Director of Regulatory and Quality Engineering at Lifecell Corporation where she oversaw the development of and led all Regulatory and Quality teams for the organization. Mira has also held senior leadership roles at a number of other Medical Device, Life Sciences, and Pharmaceutical organizations including Quality Assurance at Svelte Medical Systems, Inc., Vascular Therapies, and Micell Technologies. Mira began her career at Cordis Corporation.
Mira holds a M.E. in Mechanical Engineering, Bioengineering option and a B.S. in Mechanical Engineering, Bioengineering option, both from Cornell University, and is a Regulatory Affairs Certification (RAC) holder.

Anne Nunes Photo
Anne Nunes joined Anika on September 27, 2021 as Vice President of Operations. Most recently, Anne served as Senior Vice President of Global Operations at Smith & Nephew with responsibility for strategy and transformation. She spent eighteen years at Smith & Nephew in increasing roles of responsibility including Senior Vice President of Process Optimization, Vice President of Supply Chain for the Advanced Surgical Devices division and Chief Information Officer of the Sports Medicine business unit. Prior to Smith & Nephew, Anne held positions at Biogen Idec in Denmark, Switzerland and in the United States and she began her career at Eli Lilly & Co. in Research & Development. Anne holds an MBA from Boston University’s Questrom School of Business, where she completed the International Management Program, and a BS in Chemistry from the University of Illinois at Urbana, IL.

On February 1, 2021, Kevin Stone joined Anika as Vice President and General Manager of Sports Medicine. Kevin has over 30 years of experience in orthopedic device development and manufacturing with Zimmer Biomet, and previously Biomet, in roles such as Vice President of Emerging Technology and Innovation; Vice President and General Manager of Sports Medicine; and Vice President of Innovation for Sports Medicine, Extremities and Trauma. In addition to his extensive leadership experience, Kevin is a named Inventor on numerous US and foreign patents covering orthopedic devices in Sports Medicine, Joint Replacement, Trauma, Biologics, and Spine.

Kevin received his BS degree in Bioengineering from the University of Dayton and his MS degree in Bioengineering from Clemson University.